Eversept Partners, LP Horizon Therapeutics Public LTD CO Transaction History

Eversept Partners, LP

$1.33 Billion
Q1 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $26.7 Million - $31.2 Million	-269,495 Reduced 56.7%	205,815 $23.8 Million
Q2 2023 Nov 08, 2023	SELL	$96.34 - $112.38 $33.1 Million - $38.6 Million	-343,814 Reduced 41.97%	475,310 $48.9 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $33.1 Million - $38.6 Million	-343,814 Reduced 41.97%	475,310 $48.9 Million
Q1 2023 Nov 08, 2023	SELL	$107.32 - $113.5 $26.3 Million - $27.8 Million	-245,322 Reduced 23.05%	819,124 $89.4 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $26.3 Million - $27.8 Million	-245,322 Reduced 23.05%	819,124 $89.4 Million

Q4 2022 Nov 08, 2023	SELL	$62.39 - $113.8 $12.8 Million - $23.3 Million	-205,145 Reduced 16.16%	1,064,446 $121 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $12.8 Million - $23.3 Million	-205,145 Reduced 16.16%	1,064,446 $121 Million
Q3 2022 Nov 08, 2023	BUY	$58.92 - $84.67 $22.4 Million - $32.2 Million	380,008 Added 42.72%	1,269,591 $78.6 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $22.4 Million - $32.2 Million	380,008 Added 42.72%	1,269,591 $78.6 Million
Q2 2022 Nov 08, 2023	BUY	$79.4 - $116.36 $22.2 Million - $32.5 Million	279,644 Added 45.85%	889,583 $71 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $22.2 Million - $32.5 Million	279,644 Added 45.85%	889,583 $71 Million
Q1 2022 Nov 08, 2023	BUY	$86.42 - $109.81 $11.6 Million - $14.8 Million	134,629 Added 28.32%	609,939 $64.2 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $19.3 Million - $24.6 Million	-223,811 Reduced 26.84%	609,939 $64.2 Million
Q4 2021 Nov 08, 2023	BUY	$98.56 - $119.91 $19.6 Million - $23.9 Million	199,080 Added 31.37%	833,750 $89.8 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $19.6 Million - $23.9 Million	199,080 Added 31.37%	833,750 $89.8 Million
Q3 2021 Nov 08, 2023	SELL	$91.91 - $110.37 $2.95 Million - $3.54 Million	-32,068 Reduced 4.81%	634,670 $69.5 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $2.95 Million - $3.54 Million	-32,068 Reduced 4.81%	634,670 $69.5 Million
Q2 2021 Nov 08, 2023	SELL	$86.24 - $95.92 $2.48 Million - $2.75 Million	-28,721 Reduced 4.13%	666,738 $62.4 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $2.48 Million - $2.75 Million	-28,721 Reduced 4.13%	666,738 $62.4 Million
Q1 2021 Nov 08, 2023	BUY	$71.83 - $95.48 $11.8 Million - $15.7 Million	164,483 Added 30.98%	695,459 $64 Million
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $11.8 Million - $15.7 Million	164,483 Added 30.98%	695,459 $64 Million
Q4 2020 Nov 08, 2023	BUY	$67.0 - $84.39 $3.73 Million - $4.7 Million	55,666 Added 11.71%	530,976 $38.8 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $5.14 Million - $6.48 Million	-76,781 Reduced 12.63%	530,976 $38.8 Million
Q3 2020 Nov 08, 2023	SELL	$55.23 - $79.93 $19.2 Million - $27.7 Million	-346,981 Reduced 36.34%	607,757 $47.2 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $19.2 Million - $27.7 Million	-346,981 Reduced 36.34%	607,757 $47.2 Million
Q2 2020 Nov 08, 2023	BUY	$30.2 - $56.98 $14.5 Million - $27.3 Million	479,428 Added 100.87%	954,738 $53.1 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $28.8 Million - $54.4 Million	954,738 New	954,738 $53.1 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account